DisProt in 2022: improved quality and accessibility of protein intrinsic disorder annotation

Federica Quaglia, Bálint Mészáros, Edoardo Salladini, András Hatos, Rita Pancsa, Lucía B. Chemes, Mátyás Pajkos, Tamas Lazar, Samuel Peña-Díaz, Jaime Santos, Veronika Ács, Nazanin Farahi, Erzsébet Fichó, Maria Cristina Aspromonte, Claudio Bassot, Anastasia Chasapi, Norman E. Davey, Radoslav Davidovic, Laszlo Dobson, Arne Elofsson, Gábor Erdös, Pascale Gaudet, Michelle G. Giglio, Juliana Glavina, Javier Iserte, Valentín Iglesias, Zsófia L. Kálmán, Matteo Lambrughi, Emanuela Leonardi, Sonia Longhi, Sandra Macedo-Ribeiro, Emiliano Maiani, Julia Marchetti, Cristina Marino Buslje, Attila Meszaros, Alexander Miguel Monzon, Giovanni Minervini, Suvarna Nadendla, Juliet F. Nilsson, Marián Novotný, Christos A. Ouzounis, Nicolas Palopoli, Elena Papaleo, Pedro J. Barbosa Pereira, Gabriele Pozzati, Vasilis J. Promponas, Jordi Pujols, Alma Carolina Sanchez Rocha, Martin Salas, Luciana Rodriguez Sawicki, Éva Schád, Aditi Shenoy, Tamás Szaniszló, Konstantinos D. Tsirigos, Nevena Veljkovic, Gustavo D. Parisi, Salvador Ventura, Zsuzsanna Dosztányi, Peter Tompa, Silvio C. E. Tosatto, Damiano PiovesanNucleic Acids Res 2022 · DOI

TL;DR

The DisProt database, a key resource for intrinsically disordered protein (IDP) annotations, has been significantly updated in version 9. This release boasts improved data quality, a more user-friendly interface, and a substantial increase in content, making it easier for researchers to access and utilize information on protein disorder.

What Problem Does This Paper Address?

Proteins are traditionally thought to fold into stable, three-dimensional structures to perform their functions. However, for over two decades, the scientific community has recognized the importance of intrinsically disordered proteins (IDPs) and regions (IDRs) that lack stable structures but play crucial roles in various biological processes. Despite their growing recognition, annotating and understanding these dynamic molecules remains a challenge. Researchers need a reliable, comprehensive, and accessible resource to find experimentally validated information about IDPs and IDRs. DisProt aims to be that resource, but it needs to continuously evolve to keep pace with the rapid advancements in the field and the increasing volume of research.

Methods

DisProt 9 introduces several methodological improvements:

  • Refactored Ontology: The Intrinsically Disordered Proteins Ontology (IDPO) has been completely overhauled. This includes mapping its terms to established ontologies like the Gene Ontology (GO) and the Evidence and Conclusion Ontology (ECO), enhancing interoperability and standardization.
  • Improved Curation Process: A new reviewing process and enhanced training for curators have been implemented to ensure higher quality and consistency of annotations.
  • MIADE Standard Integration: The Minimum Information About Disorder Experiments (MIADE) guidelines are now incorporated. This standard ensures that experimental details characterizing disorder are unambiguously captured, allowing for better evaluation and comparison of data.
  • APICURON Integration: DisProt is now connected to APICURON, a system designed to credit and recognize the efforts of biocurators, fostering community engagement.
  • Document Versioning: A new versioning pattern is used to track all changes to records, improving reproducibility and allowing users to compare different versions of an entry.
  • Bioschemas Metadata: DisProt now exposes disordered region descriptions with Bioschemas metadata, facilitating data integration with other resources.

Datasets

DisProt itself is the primary dataset, continuously growing with manually curated annotations from the literature.

  • DisProt 9 Content Growth: The database now contains 2038 protein entries and 4,477 pieces of evidence, representing a 30% increase over the previous version. It also includes annotations from 2578 publications.
  • New Annotation Types: Annotations for amino acid repeats (e.g., polyE, polyK, polyR) exhibiting typical IDP properties have been added, based on indirect evidence and specific prediction criteria.
  • Experimental Evidence: The database includes data from various experimental techniques, with a notable increase in evidence derived from cryo-electron microscopy (cryo-EM).

Key Insights and Ideas

  • The "Dark Proteome" is Vast: The paper highlights that even advanced protein structure prediction tools like AlphaFold 2 still leave a significant portion of residues without confidently predicted structures, suggesting that structural disorder is more prevalent than previously thought.
  • Disorder is Key to Function: The continued growth of DisProt and the increasing number of publications on IDPs underscore the fundamental role of disorder in biological processes, from signaling to disease.
  • Standardization is Crucial: The integration of MIADE, GO, and ECO demonstrates the importance of standardized ontologies and experimental reporting for robust and comparable data in the field of protein disorder.
  • Community Effort Drives Progress: The reliance on both professional and community biocurators, coupled with the integration of APICURON for recognition, emphasizes the collaborative nature of advancing our understanding of IDPs.

Key Results

  • Content Expansion: DisProt 9 features a 30% increase in entries and evidence, and a 28% increase in annotated publications compared to DisProt 8.
  • Quality Improvement: Approximately 14% of annotations (237 entries) have undergone expert review and validation, leading to more reliable data.
  • Experimental Technique Representation: DisProt now includes 149 intrinsically disordered regions (IDRs) annotated using cryo-EM.
  • Amino Acid Composition Insights: Analysis of DisProt regions shows an enrichment of disorder-promoting residues (charged and hydrophilic) and a depletion of hydrophobic, order-promoting residues, consistent with previous findings.

Limitations and Future Work

  • Ambiguity in Experimental Data: While MIADE aims to reduce ambiguity, the paper acknowledges that some annotations still arise from experiments conducted under extreme conditions.
  • Ongoing Ontology Development: DisProt is actively involved in defining new terms for GO and ECO, and aims to map all its terms to these established ontologies in the long run.
  • Future Directions: DisProt plans to address false negative annotations, resolve inconsistencies between homologs, and expand functional descriptions. They are also working on exporting annotations to core data resources like GO, PDB, IntAct, and UniProt, and are involved in defining standard controlled vocabularies for conformational states.

Summary updated

BibTeX
@article{quaglia2022disprot,
  author = {Federica Quaglia and Bálint Mészáros and Edoardo Salladini and András Hatos and Rita Pancsa and Lucía B. Chemes and Mátyás Pajkos and Tamas Lazar and Samuel Peña-Díaz and Jaime Santos and Veronika Ács and Nazanin Farahi and Erzsébet Fichó and Maria Cristina Aspromonte and Claudio Bassot and Anastasia Chasapi and Norman E. Davey and Radoslav Davidovic and Laszlo Dobson and Arne Elofsson and Gábor Erdös and Pascale Gaudet and Michelle G. Giglio and Juliana Glavina and Javier Iserte and Valentín Iglesias and Zsófia L. Kálmán and Matteo Lambrughi and Emanuela Leonardi and Sonia Longhi and Sandra Macedo-Ribeiro and Emiliano Maiani and Julia Marchetti and Cristina Marino Buslje and Attila Meszaros and Alexander Miguel Monzon and Giovanni Minervini and Suvarna Nadendla and Juliet F. Nilsson and Marián Novotný and Christos A. Ouzounis and Nicolas Palopoli and Elena Papaleo and Pedro J. Barbosa Pereira and Gabriele Pozzati and Vasilis J. Promponas and Jordi Pujols and Alma Carolina Sanchez Rocha and Martin Salas and Luciana Rodriguez Sawicki and Éva Schád and Aditi Shenoy and Tamás Szaniszló and Konstantinos D. Tsirigos and Nevena Veljkovic and Gustavo D. Parisi and Salvador Ventura and Zsuzsanna Dosztányi and Peter Tompa and Silvio C. E. Tosatto and Damiano Piovesan},
  title = {{DisProt in 2022: improved quality and accessibility of protein intrinsic disorder annotation}},
  journal = {Nucleic Acids Res.},
  year = {2022},
  doi = {10.1093/nar/gkab1082},
}
Figure